Diabetes Care | 2019
Erratum: SGLT2 inhibitors in combination therapy: From mechanisms to clinical considerations in type 2 diabetes management. (Diabetes Care (2018) 41 (1543–1556) DOI: 10.2337/dc18-0588)
Abstract
In the article cited above, Fig. 3 was replaced. The data in the HbA1c (%) panel under 8.9 baseline was corrected. The online version of the article (https://doi.org/10.2337/dc18-0588) has been corrected.